Institution
Churchill Hospital
- 104running trials
- 43closed trials
- 11,453publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Recruiting
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recruiting
Recruiting
Recruiting
Recruiting
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Recruiting
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Active, not recruiting
Recruiting
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Recruiting
Recruiting
Recruiting
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
Recruiting
Active, not recruiting
Active, not recruiting
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
Showing 50 of 104.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers14 recruiting
- Multiple myeloma11 recruiting
- Colorectal cancer7 recruiting
- Chronic lymphocytic leukaemia5 recruiting
- Lung cancer5 recruiting
- Myelodysplastic syndromes5 recruiting
- Melanoma4 recruiting
- Myeloproliferative neoplasms4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Acute myeloid leukaemia3 recruiting
- Kidney cancer3 recruiting
- Ovarian cancer3 recruiting
- Prostate cancer3 recruiting
- Sarcoma3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Hodgkin lymphoma2 recruiting
- Mantle cell lymphoma2 recruiting
- Metastatic breast cancer2 recruiting
- Neuroblastoma2 recruiting
- Thyroid cancer2 recruiting
- Type 1 diabetes2 recruiting
- Bladder cancer1 recruiting
- Chronic kidney disease1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Haemophilia1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Pancreatic cancer1 recruiting
- Polycystic kidney disease1 recruiting
- Triple-negative breast cancer1 recruiting
- Tuberculosis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
A Real-world Study in Participants With Smoldering Multiple Myeloma
Completed
A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
Completed
Completed
Completed
Recruiting
Completed
Withdrawn
Terminated
Completed
Completed
A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)
Completed
Completed
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Completed
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
Completed
Completed
Completed
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Completed
Completed
Cardiopulmonary Testing for Potential Pancreas Transplant Candidates
Completed
Completed
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Registry name variants (28)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Churchill Hospital
Oxford, OX3 7LE
105 trials
Churchill Hospital
Headington, Oxford OX3 7LE
9 trials
Churchill Hospital Oxford
Oxford, OX3 7LE
5 trials
Cancer and Haematology Centre, Churchill Hospital
Oxford, OX3 7LE
2 trials
CCVTM, University of Oxford, Churchill Hospital
Oxford, OX3 7LE
2 trials
Churchill Hospital - Oxford Cancer & Haematology Centre
Oxford, OX3 7LE
2 trials
Oxford Churchill Hospital
Oxford, OX3 7LE
2 trials
Centre for Clinical Vaccinology and Tropical Meducine, Churchill Hospital, University of Oxford
Oxford, Oxfordshire OX3 7LE
1 trial
Churchill Hospital - Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Oxford, OX3 7LE
1 trial
Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE
Oxford
1 trial
NCT03741426WIRE - Novel Treatments in Renal Cell Cancer
Contact: Mark Sullivan (principal investigator)
Churchill Hospital - Oncology
Oxford, OX3 7LE
1 trial
Churchill Hospital, Oxford Hemophilia and Thrombosis Center
Oxford
1 trial
Churchill Hospital (Site #0515)
Oxford, OX3 7LE
1 trial
Contact: Principal Investigator
Churchill Hospital (Site 0604)
Oxford, Oxfordshire OX3 7LE
1 trial
Churchill Hospital (Site 0903)
Oxford, Oxfordshire OX3 7LJ
1 trial
Churchill Hospital (Site 1406)
Oxford, Oxfordshire OX3 7LE
1 trial
Churchill Hospital (Site 1756)
Oxford, Oxfordshire ox3 7le
1 trial
Contact: Study Coordinator
Churchill Hospital (Site 3219)
Oxford, Oxfordshire OX3 7LE
1 trial
Churchill Hospital (Site 9000)
Oxford, Oxfordshire OX3 7LE
1 trial
Department of Oncology, Cancer and Haematology Centre, Churchill Hospital
Oxford, OX3 7LE
1 trial
Lung Health Check: Oxford - Churchill Hospital, OUH
Oxford, Oxfordshire
1 trial
NCT05368298SCOOT: Sample Collection for DART
Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital
Oxford, Oxfordshire OX3 7LE
1 trial
Contact: Jiawen Dong, MB BChir, MRCP
Oxford Kidney Unit, Churchill Hospital,
Oxford, Oxfordshire OX3 7LE
1 trial
Contact: Tom Connor, Dr
The Churchill Hospital
Oxford, Oxfordshire OX3 7LE
1 trial
The Churchill Hospital (Site 1805)
Oxford, Oxfordshire OX3 7LE
1 trial
The Churchill Hospital (Site 3007)
Oxford, Oxfordshire OX3 7LE
1 trial
The Churchill Hospital (Site 7002)
Oxford, Oxfordshire OX3 7LE
1 trial
University of Oxford, The Churchill Hospital
Oxford, OX3 7DQ
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Mantle cell lymphoma9 works · 7 trials
- Chronic spontaneous urticaria4 works · 0 trials
Institution data: ROR 009vheq40 (CC0-1.0)Updated 15 Nov 2026